Review of Loteprednol Etabonate 0.5%/Tobramycin 0.3% in the Treatment of Blepharokeratoconjunctivitis

Use of a combination corticosteroid and antibiotic in a single formulation is common in the treatment of ocular inflammatory conditions for which corticosteroid therapy is indicated and there exists a risk of superficial bacterial infection. Loteprednol etabonate (LE) is a corticosteroid engineered...

Descripción completa

Detalles Bibliográficos
Autores principales: Mah, Francis S., Karpecki, Paul M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8589901/
https://www.ncbi.nlm.nih.gov/pubmed/34708391
http://dx.doi.org/10.1007/s40123-021-00401-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8589901/
https://www.ncbi.nlm.nih.gov/pubmed/34708391
http://dx.doi.org/10.1007/s40123-021-00401-x

Ejemplares similares